The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Metabolic risk score and cancer risk: pooled analysis of seven cohorts
Open accessAbstract
BACKGROUND: There are few data on the joint influence of metabolic factors on risk of separate cancers. METHODS: We analysed data on body mass index, blood pressure and plasma levels of glucose, total cholesterol and triglycerides from seven European cohorts comprising 564 596 men and women with a mean age of 44 years. We weighted those factors equally into a standardized metabolic risk score [MRS, mean = 0, standard deviation (SD) = 1], with an individual's level indicated as SDs from the sex- and cohort-specific means. Cancer hazard ratios were calculated by Cox regression with age as timescale and with relevant adjustments including smoking status. All statistical tests were two-sided. RESULTS: During a mean follow-up of 12 years, 21 593 men and 14 348 women were diagnosed with cancer. MRS was linearly and positively associated with incident cancer in total and at sites (P < 0.05). In men, risk per SD MRS was increased by 43% (95% confidence interval: 27-61) for renal cell cancer, 43% (16-76) for liver cancer, 29% (20-38) for colon cancer, 27% (5-54) for oesophageal cancer, 20% (9-31) for rectal cancer, 19% (4-37) for leukaemias, 15% (1-30) for oral cancer and 10% (2-19) for bladder cancer. In women, risk increases per SD MRS were 56% (42-70) for endometrial cancer, 53% (29-81) for pancreatic cancer, 40% (16-67) for renal cell cancer, 27% (9-47) for cervical cancer and 17% (3-32) for rectal cancer. CONCLUSION: This largest study to date on the joint influence of metabolic factors on risk of separate cancers showed increased risks for several cancers, in particular renal cell and liver cancer in men and endometrial and pancreatic cancer in women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This may decrease the measurement precision, but would rather lead to underestimation than overestimation of the association (28) .”
From Irregular eating of meals in adolescence and the metabolic syndrome in adulthood: results from a 27-year prospective cohort (2016) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 14,094
(2000) · PubMed · Cited by 13,173
Obesity : Preventing and managing the global epidemic
Akram, D. S., Astrup, A. V., Atinmo, T., Boissin, J.-L., Bray, G. A., Carroll, K. N., Chitson, P., Chen, C., Dietz, W. H., Hill, J. O., et al. (2000) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 12,945
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,317
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Flexible regression models with cubic splines
Durrleman, S., & Simon, R. M. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080504 · Cited by 2,722
World Health Organization, I. S. O. H. W. G. (2003) · Journal of Hypertension · doi:10.1097/00004872-200311000-00002 · Cited by 2,667
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J. B., Ferrannini, E., & Stern, M. P. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,400
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–146 of 146
Wang, Q., Guo, S., Huang, R., Xu, Z., Liang, D., Huang, Y., Sun, Y., Yang, W., & Jiang, L. (2025) · Cancer Medicine · doi:10.1002/cam4.71262 · Cited by 3
“Previous studies demonstrated that both hypertension and diabetes may be associated with an increased risk of HNC and reported that these conditions could be risk factors for HNC development [25–27].”
Association Between Metabolic Syndrome and Incident Cervical Cancer: A Retrospective Cohort Study
Jiang, L., Okada, A., Ishida, R., & Yasunaga, H. (2025) · Journal of Obesity · doi:10.1155/jobe/3691654 · Cited by 3
“Few studies have examined the link between cervical cancer and non-HPV factors such as metabolic syndrome (MetS), which is an established risk factor for endometrial, colorectal, gastric, and breast malignancies [7–10].”
Risk of gynaecologic cancers in women with metabolic syndrome: A systematic review & meta-analysis
Kundu, I., John, D., Ansari, I., Pavithran, K., & Idicula‐Thomas, S. (2025) · The Indian Journal of Medical Research · doi:10.25259/ijmr_588_2025 · Cited by 4
“In the case of ovarian cancer, there were two case-control studies with adjusted ORs 17,24 , and four cohort studies with median follow up of 11 years-two reported adjusted ORs 23,26 , and two reported HR scores 16,26 (Table) 3-6 ,8-10 8-10 , 16-31 16-31 .”
InfluentialYuan, Y., Liu, T., Yao, Y., Ma, Q., Sun, L., & Zhang, G. (2025) · BMC Urology · doi:10.1186/s12894-025-01812-9 · Cited by 3
Chang, C.-C., Bi, K.-W., Lin, H., Su, Y., Wang, W., Lin, C.-Y., Ting, C., Sun, M.-F., & Huang, S. (2019) · Integrative Cancer Therapies · doi:10.1177/1534735419834353 · Cited by 3
“As reported, the risk for oral cancers in male individuals increased 15%, in parallel with the standard deviation metabolic risk score increment.(39) In addition, the heat effect of dampness-heat constitution contributes to chronic inflammation resulting from increased oxidative stress and has been suggested as the me…”
BackgroundCioffi, G., Viapiana, O., Tarantini, L., Orsolini, G., Idolazzi, L., Ognibeni, F., Dalbeni, A., Gatti, D., Fassio, A., Adami, G., et al. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02465-3 · Cited by 3
“596 men and women with a mean age of 44 years followed-up for 12 years, showing increased risks for several cancers, in particular renal cell, liver, and colon cancer in men and endometrial and pancreatic cancer in women [8].”
BackgroundEffects of Polyphenol-Rich Foods on Human Health
Grosso, G. (2018) · MDPI eBooks · doi:10.3390/books978-3-03897-143-6 · Cited by 3
Chuang, M. P.-C., Hsu, W., Su, C., Yen, A. M.-F., Chen, T. H.-H., Hsu, C.-Y., & Chiu, H. (2026) · Gastroenterology · doi:10.1053/j.gastro.2026.02.045 · Cited by 2
Predictive value of transvaginal ultrasound score for detection of endometrial malignancy
Mihajlovic, S., Vasiljević, M., Jurisic, A., Kisić-Tepavčević, D., Dimitrijevic, D., & Nejković, L. (2016) · Clinical and Experimental Obstetrics & Gynecology · doi:10.12891/ceog3068.2016 · Cited by 2
Metabolic-associated fatty liver disease (NAFLD) as a cancer risk factor
Сергеевна, К. Т., & Livzan, M. A. (2023) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-211-3-120-127 · Cited by 2
Aljahdali, A., & Shi, Z. (2024) · Nutrients · doi:10.3390/nu16060760 · Cited by 2
“…abnormalities, including central obesity, impaired glucose metabolism, elevated blood pressure, and dyslipidemia [1], that have been identified as risk factors for incident cardiovascular diseases (CVDs), all-cause mortality, cardiovascular mortality [2,3], and other chronic diseases [4,5].”
BackgroundIqbal, K., Intemann, T., Börnhorst, C., Zhang, J., & Aleksandrova, K. (2025) · AJE Advances Research in Epidemiology · doi:10.1093/ajeadv/uuaf005 · Cited by 3
Gao, K., & Lin, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-02921-z · Cited by 3
Metabolic syndrome and bladder cancer
Righetto, M., Modonutti, D., Celso, F., Fulcoli, V., & Mancini, M. (2022) · Panminerva Medica · doi:10.23736/s0031-0808.22.04641-9 · Cited by 2
Cardiorespiratory Endurance is Associated with Metabolic Syndrome Severity in Men
Sverchkov, V. V., & Быков, Е. В. (2023) · Journal Biomed · doi:10.33647/2074-5982-19-2-61-68 · Cited by 2
Jordan, S. J., & Webb, P. M. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192864642.003.0012 · Cited by 2
Krzysztof, S., Bencherki, A., Nils, T., Sagen, E., & Elzanaty, S. (2020) · Archive of Urological Research · doi:10.17352/aur.000025 · Cited by 3
Xu, J., Wang, X., Du, Q., Qu, P., & Liu, C. (2023) · Clinical Medicine Insights Oncology · doi:10.1177/11795549231152308 · Cited by 1
Aljahdali, A., Goodrich, J. M., Dolinoy, D. C., Kim, H. M., Ruiz-Narváez, E., Baylín, A., Cantoral, A., Torres-Olascoaga, L. A., Téllez‐Rojo, M. M., & Peterson, K. E. (2023) · Epigenomes · doi:10.3390/epigenomes7010004 · Cited by 1
“A cluster of cardiometabolic abnormalities, called metabolic syndrome [5,6], is considered a risk factor for cardiovascular disease (CVD) incidence, cardiovascular-related mortality, all-cause mortality [7,8], and other chronic diseases [9,10].”
BackgroundNitric Oxide-cGMP-PKG Signaling in the Cardioprotective Effects of Phosphodiesterase 5 Inhibitors
Kukreja, R. C., Das, A., Koka, S., Samidurai, A., & Xi, L. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-24778-1_6 · Cited by 1
Zhang, K., Han, Y., Yu, G., Gu, F. M., Gu, Z. X., Liang, J. Y., Zhao, J. Y., Zhang, T., Gao, M., Cai, T. Y., et al. (2024) · International Journal of COPD · doi:10.2147/copd.s448332 · Cited by 1
Epigenomics: The Silent Notes of Metabolic Syndrome
Nair, S. P., Darshan, R., Thekkekkara, D., & Manjula, S. N. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-75686-3_20 · Cited by 1
Could metabolic risk factors contribute to the development of cervical cancer?
Noda, M. F., Eduardo, C.-R., Hernández-Menéndez, M., & Raque, D.-B. (2019) · Annals of Clinical Endocrinology and Metabolism · doi:10.29328/journal.acem.1001011 · Cited by 1
“In the same way, excess weight, which has a stimulatory effect on carcinogenesis, is associated with a higher incidence of some gynecological cancers such as endometrial, ovarian and cervical cancers [14-17].”
BackgroundJiang, S., Zhi-He, X., Xu, Q., Kun, D., Yuan, M., Yong, G., & Sheng-tian, Z. (2020) · Archive of Urological Research · doi:10.17352/aur.000026 · Cited by 1
Are Nutrition Professionals Involved in Nutrition Education? A Cross Sectional Study in Italy
Cena, H., Bazzano, R., Roggi, C., & Turconi, G. M. C. (2015) · Journal of Nutrition and Health Sciences · doi:10.15744/2393-9060.2.401
Obermair, F., Popper, U., Romeder, F., & Rumpold, H. F. (2016) · Wiener klinisches Magazin · doi:10.1007/s00740-016-0107-4 · Cited by 1
O uso de microRNA para tratamento do câncer de próstata: estudos in vitro e in vivo
Iscaife, A. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-22082016-104926
[Bite marks as evidence in violent incidents, rapes and murders. Report of 2 cases].
Stavrianos, C., & Hourdakis, K. (1989) · PubMed
Dietary Patterns among Overweight/Obese Hispanic Women at High Risk for Type 2 Diabetes
Arias‐Gastélum, M. (2018)
Goh, V. H. H. (2021) · World Journal of Public Health · doi:10.11648/j.wjph.20210601.14
Epidemiological Impact of Pancreatic Cancer
Maisonneuve, P. (2021) · doi:10.1002/9781119570097.ch49
E-Manuscript Article Summaries
Current Oncology Editorial Office (2011) · Current Oncology · doi:10.3747/co.v18i2.897
Relationship between Metabolic Syndrome on Grade and Stage of Urothelial Carcinoma of Bladder
Kundu, B., Ahmed, F., Uddin, M. H., Uddin, M. Z., Bari, A. A., & Islam, D. M. R. (2022) · Scholars Journal of Applied Medical Sciences · doi:10.36347/sjams.2022.v10i12.041
“In this context we tried to find out any significant relationship between MS and grade/stage of bladder cancer in our population subset [6].”
Juhász, Á., Hajdú, A., & Dank, M. (2023) · Cardiologia Hungarica · doi:10.26430/chungarica.2023.53.2.144
“Obesity research & clinical practice 2013; 7(5): e330–41.”
BackgroundInfluentialInoue, G. N. C. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-16062023-162147
Hao, C., Lei, Z., Zhang, J., Hu, Q., Guo, F., Mo, Z., Huang, B., & Liu, C. (2023) · Research Square · doi:10.21203/rs.3.rs-3447796/v1
The metabolic profile of lean patients with esophageal adenocarcinoma and Barrett’s esophagus
Sawas, T., Benson, J. T., Allen, A. M., Wang, K., Wani, S., Iyer, P. G., & Katzka, D. A. (2025) · Diseases of the Esophagus · doi:10.1093/dote/doaf080
Li, B., Li, M., Qi, X., Tong, T., & zhang, G. (2024) · Figshare · doi:10.6084/m9.figshare.25621853
Syed, M. A., Al Nuaimi, A. S., Latif Zainel, A. J. A., & Qotba, H. A. A. (2020) · Figshare · doi:10.6084/m9.figshare.12237377
Xia, B., Peng, J., Enrico, D. T., Lu, K., Cheung, E. C., Kuo, Z., He, Q., Tang, Y., Liu, A., Fan, D., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16767556
Quagliarini, E., Caputo, D. D., Cammarata, R., Caracciolo, G., & Pozzi, D. (2024) · Figshare · doi:10.6084/m9.figshare.26572006
Céspedes, P., Buigues, C., Torregrosa, M. D., Martínez‐Arnau, F. M., Cauli, O., & Trapero, I. (2026) · Pathophysiology · doi:10.3390/pathophysiology33020031
Safety of robotic liver resection under antiplatelet therapy: a propensity score-matching study
Esposito, G., Manicardi, M., Ross, S. B., Vanterpool, G., Haripersad, O., Covilo, K. M., Eid, M. K., Axentiev, A., & Sucandy, I. (2026) · Surgical Endoscopy · doi:10.1007/s00464-026-13226-1
“This issue is increasingly relevant, as the number of patients requiring ongoing ATT during LR is expected to rise in parallel with the growing prevalence of metabolic syndrome, a condition progressively associated with the development of both primary and secondary hepatic malignancies [29].”
Rodrigues, R., Soares, R. A., Vasconcelos, M. H., & Xavier, C. P. R. (2026) · Pancreatology · doi:10.1016/j.pan.2026.10.025
Metadata
- Authors
- Stocks, T., Bjørge, T., Ulmer, H., Manjer, J., Häggström, C., Nagel, G., Engeland, A., Johansen, D., Hallmans, G., Selmer, R., Concin, H., Tretli, S., Jonsson, H., & Stattin, P.
- Affiliations
- Lund University (SE)
- Cancer Registry of Norway (NO)
- Innsbruck Medical University (AT)
- Umeå University (SE)
- Universität Ulm (DE)
- Norwegian Institute of Public Health (NO)
- Corresponding author
- Stocks, Tanja
- ORCID
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-02-03
- Volume
- 44
- Issue
- 4
- Pages
- 1353-1363
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- PMC
- PMC4588859
- OpenAlex
- W2132610504
- Cited by
- 146
- References
- 40
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 10 · 2023: 15 · 2022: 11 · 2021: 12 · 2020: 15 · 2019: 16 · 2018: 14 · 2017: 13 · 2016: 16 · 2015: 8
- FWCI
- 7.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- International Journal of Epidemiology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by-nc)
- BIBSYS Brage (BIBSYS (Norway)) (submittedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- Funders
- Wereld Kanker Onderzoek Fonds
- World Cancer Research Fund (2007/09)
- Norwegian Institute of Public Health
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- metabolic risk score, cancer risk, body mass index, blood pressure, plasma glucose, total cholesterol, triglycerides, renal cell carcinoma, liver cancer, endometrial cancer, pancreatic cancer, colon cancer, esophageal cancer, rectal cancer, leukemia, oral cancer, bladder cancer, cervical cancer, sex differences
- MeSH terms
- Adult, Blood Glucose, Blood Pressure, Cholesterol, Europe, Female, Humans, Male, Middle Aged, Neoplasms, Risk Factors, Triglycerides, Cohort Studies, Body Mass Index, Proportional Hazards Models, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
